An article about our company was published in the Mainichi Shimbun.

2024/03/21

毎日新聞朝刊の科学面「科学の森」にて、『生成ＡＩでたんぱく質設計』という記事に弊社が取り上げられました。

https://mainichi.jp/articles/20240321/ddm/016/040/019000c

RevolKa raised funds through a startup loan program

RevolKa announces the closing of ￥250 million series A extension funding to accelerate Drug-Discovery programs

RevolKa Started joint research of a drug discovery program for rare diseases

Related Articles